Predicting the carcinogenic potential of pharmaceuticals in rodents using molecular structural similarity and E-state indices

Regulatory Toxicology and Pharmacology

Volumn 38, Issue 3, 2003, Pages 243-259

  Contrera, Joseph F ^a   Matthews, Edwin J ^a   Benz, R Daniel ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Carcinogenicity; Computational toxicology; E state descriptors; Electrotopological; In silico; Predictive modeling; Quantitative structure activity relationship (QSAR)

Indexed keywords

ACICLOVIR; ADAPALENE; AMFEBUTAMONE; AMPHETAMINE; AZATADINE; AZATHIOPRINE; BENZYL ACETATE; BROMEBRIC ACID; BROTIZOLAM; BUSPIRONE; CABERGOLINE; CAPTAN; CARMUSTINE; CHLORDIAZEPOXIDE; CHLORENDIC ACID; CIMETIDINE; CITRAL; CLEMASTINE; CLOFIBRATE; DIBROMOCHLOROMETHANE; DICLOFENAC; DIDANOSINE; DIETHANOLAMINE; DOXYLAMINE; EMODIN; EPHEDRINE; ETODOLAC; ETRETIN; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; UNINDEXED DRUG;

ACCURACY; ARTICLE; CARCINOGENIC ACTIVITY; CARCINOGENICITY; COMPUTER MODEL; COMPUTER PROGRAM; EXPERIMENTAL MODEL; FEASIBILITY STUDY; MAXIMUM TOLERATED DOSE; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RODENT; SEX DIFFERENCE; VALIDATION PROCESS;

RODENTIA;

EID: 0242624535     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0273-2300(03)00071-0     Document Type: Article

References (42)

1. Abou-Shaaban R.R., al-Khamees H.A., Abou-Auda H.S., Simonelli A.P. Atom level electrotopological state indexes in QSAR: designing and testing antithyroid agents. Pharm. Res. 13:1996;129-136.
2. Ashby J., Tennant R.W. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals by the US NTP. Mutat. Res. 257:1991;229-306.
3. Brown R.D., Martin Y.C. Use of structure-activity data to compare structure-based clustering methods and descriptors for use in compound selection. J. Chem. Inf. Comput. Sci. 36:1996;572-584.
4. Cash G.H. Prediction of the genotoxicity of aromatic and heteroaromatic amines using electrotopological state indices. Mutat. Res. 491:2001;31-37.
5. Contrera J.F., Jacobs A.C., DeGeorge J.J. Carcinogenicity testing and the evaluation of regulatory requirements for pharmaceuticals. Regul. Toxicol. Pharmacol. 25:1997;130-145.
6. Cooper J.A., Saracci R., Cole P. Describing the validity of carcinogen screening tests. Br. J. Cancer. 39:1979;87-89.
7. Cronin M.T., Aptula A.O., Dearden J.C., Duffy J.C., Netzeva T.I., Patel H., Rowe P.H., Schultz W.T., Worth A.P., Voutzoulidis K., Schuurmann G. Structure-based classification of antibacterial activity. J. Chem. Inf. Comput. Sci. 42:2002;869-878.
8. Forrest S. Genetic algorithms: principles of natural selection applied to computation. Science. 261:1993;872-878.
9. Gini G., Lorenzini M., Benefenati E., Grasso P., Bruschi M. Predictive carcinogenicity: a model for aromatic compounds with nitrogen-containing substituents, based on molecular descriptors using an artificial neural network. J. Chem. Inf. Comput. Sci. 39:1999;1076-1080.
10. Gold L.S., Bernstein L., Magaw R., Sloane T.H. Interspecies extrapolation in carcinogenesis: prediction between rats and mice. Environ. Health Perspect. 81:1989;211-219.
11. Gold L.S., Manley N., Slone T., Garfinkel G., Rohrback L., Ames B.N. The fifth plot of the carcinogenic potency database: results of animal bioassays published in the general literature through 1988, by the National Toxicology Program through 1989. Environ. Health Perspect. 100:1993;65-135.
12. Gough J., Hall L.H. Modeling the toxicity of amide herbicides using the electrotopological state. Environ. Toxicol. Chem. 18:1999;1069-1075.
13. Gough J., Hall L.H. Modeling antileukemic activity of carboquinones with electrotopological state and chi indices. J. Chem. Inf. Comput. Sci. 39:1999;356-361.
14. Greene N. Computer systems for the prediction of toxicity: an update. Adv. Drug Deliv. Rev. 54:2002;417-431.
15. Hall L.H., Mohney B., Kier L.B. The electrotopological state: structure information at the atomic level for molecular graphs. J. Chem. Inf. Comput. Sci. 31:1991;76-82.
16. Hall L.H., Mohney B., Kier L.B. The electrotopological state: an atom index for QSAR. Quant. Struct.-Act. Relat. 10:1991;43-51.
17. Hall L.H., Kier L.B. Electrotopological state indices for atom types: a novel combination of electronic, topological and valence state information. J. Chem. Inf. Comput. Sci. 35:1995;1039-1045.
18. Hall L.H., Kier L.B. Issues in representation of molecular structure: the development of molecular connectivity. J. Mol. Graph. Model. 2001;4-18.
19. Hall L.B., Kier L.B., Brown B.B. Molecular similarity based on novel atom type electrotopological state indices. J. Chem. Inf. Comput. Sci. 35:1995;1074-1080.
20. Hall L.H., Vaughn T.A. QSAR of phenol toxicity using electrotopological state and kappa shape indices. Med. Chem. Res. 7:1997;407-416.
21. Haseman J.K. A re-examination of false-positive rates for carcinogenicity studies. Fundam. Appl. Toxicol. 3:1983;334-339.
22. Haseman J.K., Clark A. Carcinogenicity results for 114 laboratory animal studies used to ass the predictivity of four in vitro genetic toxicity assays for rodent carcinogenicity. Environ. Mol. Mutagen. 16(Suppl. 18):1991;15-31.
23. Haseman J.K., Lockhart A. Correlations between chemically related site-specific carcinogenic effects in long-term studies in rats and mice. Environ. Health Perspect. 101:1993;50-54.
24. Haseman J.K., Winbush J.S., O'Donnell M.W. Jr. Use of dual control groups to estimate false positive rates in laboratory animal carcinogenicity studies. Fundam. Appl. Toxicol. 7:1986;573-584.
25. Huff J., Haseman J. Long-term chemical carcinogenesis experiments for identifying potential human cancer hazards: collective database of the National Cancer Institute and National Toxicology Program. Environ. Health Perspect. 96:1991;23-31.
26. Kier L.B., Hall L.H. Lemont B. Molecular Structure Description: The Electrotopological State. 1999;Academic Press, New York.
27. Kier L.B., Hall L.H. The electrotopological state: structure modeling for QSAR and database analysis. James D., Balaban Alexandru T. Topological Indices and Related Descriptors in QSAR and QSPR. 1999;Gordon and Breach, Reading, UK.
28. Kier L.B., Hall L.H. Molecular Structure Description: The Electrotopological State. 1999;Academic Press, New York.
29. Kier L.B., Hall L.H. Database organization and searching with E-state indices. SAR QSAR Environ. Res. 12:2001;55-74.
30. Kubinyi H. Variable selection in QSAR studies. I. An evolutionary algorithm. Quant. Struct.-Act. Relat. 13:1994;285-294.
31. Kubinyi H. Variable selection in QSAR studies. II. A highly efficient combination of systematic search and evolution. Quant. Struct.-Act. Relat. 13:1994;393-401.
32. Liu R., Sun H., So S.S. Development of quantitative structure-activity relationship models for early ADME evaluation in drug discovery. 2. Blood-brain barrier penetration. J. Chem. Inf. Comput. Sci. 41:2001;1623-1632.
33. Matthews E.J., Benz R.D., Contrera J.F. Use of toxicological information in drug design. J. Mol. Graph. Model. 18:2000;605-615.
34. Matthews E.J., Contrera J.F. A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSAR-ES software. Regul. Toxicol. Pharmacol. 28:1998;242-264.
35. Maw H.H., Hall L.H. E-state modeling of dopamine transporter binding. Validation of the model for a small data set. J. Chem. Inf. Comput. Sci. 40:2000;1270-1275.
36. McConnell E.E., Solleveld H.A., Swenberg J.A., Boorman G.A. Guidelines for combining neoplasms for evaluation of rodent carcinogenesis studies. JNCI. 76:1986;283-394.
37. McKinney J.D., Richard A., Waller C., Newman M.C., Gerberick F. The practice of structure activity relationships (SAR) in toxicology. Toxicol. Sci. 56:2000;8-17.
38. Office of Science Technology Policy (OSTP), 1985. Chemical carcinogens: a review of the science and its associated principles. Fed. Regist. 50, 10371-10442.
39. Rogers D., Hopfinger A.J. Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships. J. Chem. Inf. Comput. Sci. 34:1994;854-866.
40. Tennant R.W. Stratification of rodent carcinogenicity bioassay results to reflect relative human hazard. Mutat. Res. 286:1993;111-118.
41. Testa T., Kier L.B. The concept of molecular structure in structure-activity relationships and drug design. Med. Res. Rev. 11:1991;35-48.
42. Willet P., Barnard J.M., Downs G.M. Chemical similarity searching. J. Chem. Inf. Comput. Sci. 38:1998;983-996.